Cargando…

Cardiorespiratory fitness assessment and prediction of peak oxygen consumption by Incremental Shuttle Walking Test in healthy women

INTRODUCTION: Preliminary studies have showed that the Incremental Shuttle Walking Test (ISWT) is a maximal test, however comparison between ISWT with the cardiopulmonary exercise test (CEPT) has not yet performed in the healthy woman population. Furthermore, there is no regression equation availabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Liliana Pereira, Leite, Hércules Ribeiro, de Matos, Mariana Aguiar, Neves, Camila Danielle Cunha, Lage, Vanessa Kelly da Silva, da Silva, Guilherme Pinto, Lopes, Gladson Salomão, Chaves, Maria Gabriela Abreu, Santos, Joyce Noelly Vitor, Camargos, Ana Cristina Resende, Figueiredo, Pedro Henrique Scheidt, Lacerda, Ana Cristina Rodrigues, Mendonça, Vanessa Amaral
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366724/
https://www.ncbi.nlm.nih.gov/pubmed/30730949
http://dx.doi.org/10.1371/journal.pone.0211327
Descripción
Sumario:INTRODUCTION: Preliminary studies have showed that the Incremental Shuttle Walking Test (ISWT) is a maximal test, however comparison between ISWT with the cardiopulmonary exercise test (CEPT) has not yet performed in the healthy woman population. Furthermore, there is no regression equation available in the current literature to predict oxygen peak consumption (VO(2) peak). Thus, this study aimed to compare the ISWT with CEPT and to develop an equation to predict peak oxygen uptake (VO(2) peak) in healthy women participants. METHODS: First, the VO(2) peak, respiratory exchange ratio (R peak), heart rate max (HR max) and percentage of predicted HR max (% predicted HR max) were evaluated in the CEPT and ISWT (n = 40). Then, an equation was developed to predict the VO(2) peak (n = 54) and its validation was performed (n = 20). RESULTS: There were no significant differences between the ISWT and CEPT of VO(2) peak, HR max and % predicted HR max values (P>0.05), except for R peak measure in the ISWT (1.22 ± 0.13) and CEPT (1.18 ± 0.1) (P = 0.022). Therefore, both tests showed a moderate positive correlation of VO(2) peak (r = 0.51; P = 0.0007), HR max (r = 0.65; P<0.0001) and R peak (r = 0.55; P = 0.0002) and the Bland-Altman analysis showed agreement of VO(2) peak (bias = -0.14). The distance walked on ISWT and age explained 36.3% (R(2) Adjusted = 0.363) of the variance in VO(2) peak. The equation developed was VO(2) peak (predicted) = 19.793 + (0.02 x distance walked)—(0.236 x age). There was no statistically significant difference between the VO(2) peak measured directly and the predicted, and the Bland-Altman analysis showed agreement (bias = 1.5 ml/kg/min). CONCLUSION: ISWT is a maximal test showing similar results compared to the CEPT, and the predicted equation was valid and applicable for VO(2) peak assessing in young adult healthy women.